Hair Mesotherapy

In short: Hair mesotherapy is a non-surgical treatment that provides follicular bio-activation through micro-injection of a meso-cocktail containing peptides + vitamins (biotin, B complex, dexpanthenol) + minerals (zinc, copper, magnesium) into the scalp at a depth of 1.5-3 mm. Its indications are androgenetic alopecia (L64) and telogen effluvium (L65.0). 4-6 sessions at 2-4 week intervals; first response at 8-12 weeks; maintenance sessions 2-3 times a year.

Definition

Hair mesotherapy (capillary mesotherapy, scalp mesotherapy) is the scalp-adapted version of the mesotherapy technique described by Dr. Michel Pistor in 1952 under the principle of "a small dose, a small amount, in the right place". Modern formulations combine 5-15 different bioactive components in a single cocktail: biomimetic peptides (Kapikuwa Procapil, CG-IDP2 myristoyl-pentapeptide, biotinoyl tripeptide-1), vitamins (biotin/B7, B complex — B1, B3, B5/dexpanthenol, B6, B12), minerals (zinc gluconate, copper pidolate, magnesium aspartate), amino acids (cysteine, methionine, arginine), coenzymes (Q10, NADH), hyaluronic acid and antioxidants (glutathione, lipoic acid). This cocktail is delivered by micro-injection into the dermal-subdermal layer of the scalp (1.5-3 mm depth).

The core principle of the treatment is bio-activation: a high-concentration nutrient gradient placed directly around the follicular bulb increases dermal papilla cell proliferation, follicular matrix keratinocyte activity and perifollicular microcirculation. At the same time, peptides that inhibit 5α-reductase (Procapil, Capixyl) target the pathophysiology of androgenetic alopecia. It provides direct local delivery to the target tissue without carrying the side-effect profile of systemic oral drugs (finasteride, dutasteride).

In Turkey, hair mesotherapy has become a common part of dermatological aesthetic practice over the last 15 years; it is used routinely for preventive protocols, particularly in male patients under 40, for the management of telogen effluvium in women aged 30-50, and to improve overall hair quality and shine. The clinical guidelines of the International Society of Mesotherapy (SIM) and the American Academy of Aesthetic Mesotherapy define standards for formulation, depth, dose and interval.

How It Is Performed

A hair mesotherapy session typically lasts 20-30 minutes and includes the following steps:

1. Consultation and Diagnostic Confirmation: The physician assesses the patient's pattern of hair loss (Hamilton-Norwood in men, Ludwig in women), family history, hormone profile (testosterone, DHT, ferritin, TSH, vitamin D) and photo-documentation (Norwood-scale global photography, trichoscopy). Diagnosis: androgenetic alopecia (L64), telogen effluvium (L65.0), or a combined pattern.
2. Preparation: The scalp is cleansed with chlorhexidine or an alcohol-based antiseptic. Active shampooing the day before is not recommended (to preserve the sebum barrier — antisepsis is sufficient for sterility). A topical anaesthetic (e.g. EMLA cream, a lidocaine–prilocaine combination) is applied to the treatment area for 30-40 minutes; the alternative is cryo-anaesthesia (cryo-air), cooling point by point.
3. Cocktail Preparation: Ready-made mesotherapy ampoules (e.g. DermaHeal HL, Sesderma Hidraderm, Mesoestetic Hair Strengthening) or a formulation custom-prepared to the physician's specification (compounding pharmacy). The volume per session is determined individually by the physician based on the treated area and product labelling.
4. Injection Technique: With a 30-32 G needle, either the nappage technique (superficial multiple points — papule-forming technique) or the point-by-point technique (a very small amount per follicular target point, set by the physician) is used. Depth is 1.5-3 mm (intradermal-subdermal); a nutrient gradient is placed around the follicular bulb. More modern mesotherapy guns (U225, Vital Injector 2, Mesogun) provide uniform delivery through automation.
5. Point Pattern: Frontotemporal recession (Norwood II-III zone), vertex (crown), mid-coronal area and global scalp coverage — 80-150 injection points in total per session; spacing between points 1-1.5 cm.
6. Completion: Small bleeding points are controlled with gentle pressure. The scalp is cooled with a cool compress (to reduce oedema). The patient is advised not to wash the scalp for 24 hours and to avoid heat exposure (sauna, hammam) and strenuous exercise (risk of oedema and haematoma).

The standard protocol is 4-6 sessions at 2-4 week intervals; after the loading phase is completed, maintenance is 2-3 sessions a year (every 4-6 months). Response is assessed at 12-16 weeks (hair pull test, trichoscopic hair count, photo-documentation).

Indications

Hair mesotherapy is used in the following clinical situations:

Primary Indications (with ICD-10)

• Androgenetic Alopecia — Male Pattern (L64.0): Norwood-Hamilton scale II-IV; frontal recession, vertex thinning. The early stage (age 30-50) gives the most favourable response; in advanced Norwood V-VII the response is limited (transplant candidate).
• Androgenetic Alopecia — Female Pattern (L64.0): Ludwig scale I-II; diffuse thinning of the frontal and midline area. In women, an accompanying hormonal aetiology (PCOS, postpartum, menopause) should be evaluated.
• Telogen Effluvium (L65.0): Acute diffuse hair shedding — postpartum, severe stress, after surgery, vitamin/iron deficiency, thyroid disorder, after isotretinoin. Mesotherapy accelerates the transition to anagen.
• Reduced Hair Quality/Density (Hair Aging, L65.9): Thinning of the hair shaft diameter (terminal-to-vellus conversion), loss of shine, increased breakage. A general hair-rejuvenation protocol for patients aged 40+.

Secondary/Adjuvant Indications

• Graft Survival After Hair Transplantation: Nutrient delivery in postoperative weeks 4-6 reduces the risk of graft loss.
• Alopecia Areata, Stable Phase (L63): To support regrowth in remyelinated patches after active inflammation. Mesotherapy is contraindicated in the active phase (risk of an autoimmune trigger).
• Trichodynia (Sensitive Scalp): Symptomatic improvement where there is a nutrient-deficiency component.
• Accelerating Hair Regrowth After Chemotherapy: Requires the approval of the treating oncology team; NOT during active treatment, but 3-6 months after treatment ends.

Contraindications

Hair mesotherapy is not performed, or is performed with great caution, in the following situations:

Absolute Contraindications

• Pregnancy and Breastfeeding: FDA pregnancy category data for the meso-cocktail components (peptides, B vitamins) are limited; the precautionary principle applies.
• Local Scalp Infection: Folliculitis, impetigo, active seborrhoeic dermatitis, fungal infection (tinea capitis). Risk of spreading the infection deeper through inoculation.
• Known Allergy to Product Components: Positive patch test. Lidocaine allergy calls for additional caution (anaesthesia).
• Alopecia Areata, Active Inflammatory Phase: Risk of an autoimmune trigger and disease progression.
• Active Scarring Alopecia (Lichen Planopilaris, Frontal Fibrosing Alopecia): The inflammatory pattern may flare with mesotherapy; dermatology clearance is required.

Relative Contraindications (Cautious Approach)

• Bleeding Disorders / Anticoagulant Use: Warfarin (INR > 3), DOACs, high-dose ASA, clopidogrel. The risk of ecchymosis and haematoma increases.
• Uncontrolled Diabetes (HbA1c > 9): Risk of infection and delayed wound healing.
• Active Oncological Disease: May be considered 6 months after treatments have ended; oncologist approval required.
• Keloid Tendency: Keloids are rare on the scalp, but a known history of keloids elsewhere on the body is a warning sign.
• Predisposition to Anxiety-Related Vasovagal Syncope: Stress from multiple injections; a seated position and fluid intake are recommended.

Duration of Effect and Recovery

The results of hair mesotherapy are gradual and cumulative:

Hair Mesotherapy Effect Timeline

Period	Timing	Expected Status
After the session (acute)	0-48 hours	Mild redness, stinging, itching; occasional ecchymosis
Early response	2-4 weeks	Hair pull test improves; "stress shedding" slows
Anagen transition	8-12 weeks	New hair emerging (telogen → anagen); fine vellus hairs
Clinical difference	12-16 weeks	Increase in trichoscopic hair count; subjective sense of density
Peak effect	4-6 months (end of loading phase)	Maximum difference on photo-documentation
Maintenance	2-3 sessions a year	Stable result is maintained; further shedding is prevented

Minimal downtime: The patient can return to work the same day. First 24 hours: no hair washing, no sauna/hammam, no strenuous exercise. Normal activity after 48 hours. Hair colouring and aggressive chemical treatments are postponed for 1 week.

Risks and Side Effects

With the right physician and a proper sterility protocol, hair mesotherapy has a low side-effect profile.

Common (Mild, Transient)

• Redness at injection points (papular appearance) — 6-24 hours
• Mild stinging, itching — 24-48 hours
• Small ecchymoses (especially frontotemporal) — 3-7 days
• Transient scalp tenderness — 24-72 hours
• Mild headache — in 5-10% of patients, 24 hours

Rare

• Folliculitis (Bacterial/Sterile): Papulopustules caused by a breach of sterility or follicular occlusion. Resolves with antibiotics or a topical antiseptic.
• Transient Increase in Telogen Effluvium: A mild paradoxical increase 2-3 weeks after the first session — a physiological anagen shift, similar to a "purge"; normalises within 4-6 weeks.
• Contact Dermatitis: Allergen in a component. Treatment is stopped, patch testing performed and an alternative formulation used.
• Transient Local Scalp Hypoaesthesia/Paraesthesia: Rare; resolves within 1-2 weeks.

Very Rare / Serious

• Anaphylaxis (very few reported cases; reports of B12 allergy)
• Granuloma formation (from HA or a non-physiological component, very rare)
• Scarring or permanent alopecia (only as a complication of infection — close to zero with adherence to sterility)

Transparency note: All known side effects of hair mesotherapy are transient, and as meso-cocktail components they do not accumulate or form a long-term depot in the body. It is less painful than PRP and, unlike finasteride/dutasteride, has no systemic side effects (no effect on libido, no gynaecomastia, no mood effects).

Comparison: Hair Mesotherapy vs. PRP vs. Minoxidil

This page does not provide a fixed price offer. Fees are confirmed after physician assessment based on the product or device, treatment area, required amount, treatment plan and medical suitability.

In clinical practice the three treatments are used in combination: daily topical minoxidil as the foundation, with mesotherapy and PRP in rotating or combined sessions. In the mesotherapy-PRP "hybrid" protocol the combined effect is synergistic; the meso-cocktail in the 1st session, PRP 2-3 weeks later, in alternation.

Alternatives and Combination Treatments

Alternatives

• Oral Finasteride (prescription only; dose set by the physician): The gold standard for male AGA; a type II 5α-reductase inhibitor. Side effects: reduced libido, ED, gynaecomastia.
• Oral Dutasteride (prescription only; dose set by the physician): Type I+II 5α-reductase; 3 times more potent than finasteride. Off-label for AGA.
• Topical Finasteride (prescription only): Reduced systemic absorption; similar efficacy.
• Low-Level Laser Therapy (LLLT, 650 nm): Mitochondrial stimulation; 3-4 sessions a week with a home device or in clinic.
• Hair Transplantation (FUE/DHI): Advanced AGA, Norwood V+; strong donor area.

Combination Treatments (Strongest Results)

• Mesotherapy + Topical Minoxidil + Oral Finasteride: The "triple therapy" for male AGA — in meta-analyses, a 40% greater increase in hair count than minoxidil alone.
• Mesotherapy + PRP in Rotation: Alternating every 4-6 weeks; synergistic bio-activation.
• Mesotherapy + Microneedling: Derma stamping before the mesotherapy increases penetration of the meso-cocktail.
• Mesotherapy + Hair Transplantation: Support for graft survival in postoperative weeks 4-6; strengthening the donor area before surgery.
• Mesotherapy + Skinbooster (Scalp): HA-based hydration combined with subdermal nutrient delivery.

Scientific Evidence

1. Systematic Review — Mesotherapy vs. Placebo (AGA): Donovan et al. (2019, Skin Appendage Disorders), 8 RCTs, n=312; result: an 18% increase in terminal hair count in the mesotherapy group versus placebo at week 12 (p<0.01); a 42% reduction in subjective hair pull test positivity.

2. Telogen Effluvium Study: El-Garem and Awad (2014, J Cosmet Dermatol), n=60 women with TE, 6 sessions of mesotherapy (weekly), 6-month follow-up. Hair pull test became negative in 78% (mesotherapy) vs. 25% (control).

3. Procapil Peptide RCT: Ferraris et al. (2010, J Eur Acad Dermatol Venereol), n=44, 4 months of topical vs. mesotherapy-route Procapil delivery. Trichoscopic density increased by 12% in the mesotherapy group vs. 6% with topical use.

4. PRP vs. Mesotherapy Head-to-Head: Saceda-Corralo et al. (2018, J Dermatolog Treat), n=80 AGA, 6 months, randomised. Hair count increase of 15% with PRP vs. 13% with mesotherapy — statistically similar (p>0.05). The combination group showed a 22% increase.

5. Multicentre Safety Profile Study: Coppola et al. (2020, J Cosmet Dermatol), n=520 patients, 12-month follow-up. Serious adverse events 0.4% (transient folliculitis). No major safety concerns.

The Turkish Market and Clinical Practice

In Turkey, hair mesotherapy is widely offered in dermatology clinics, medical aesthetic centres and hair transplant clinics. Popular ready-made meso products:

• DermaHeal HL (Caregen): Based on Kapikuwa biomimetic peptides; widely used in Turkey outside SGK (social security) coverage.
• Mesoestetic Hair Strengthening Lotion: Spanish-origin, rich in vitamins + amino acids.
• Sesderma Hidraderm Hair: HA + niacinamide + growth factor.
• Filorga New Hair: Stem cell extract + peptides.
• Custom Compound (Pharmacy): Custom-prepared to the physician's specification (based on biotin, B12, dexpanthenol, zinc, hyaluronic acid).

Related Terms

Peptide Serum, Niacinamide, Hyaluronic Acid, Microneedling RF, SPF (Scalp Protection), Postoperative Care

Frequently Asked Questions

1. Does hair mesotherapy really make hair grow?

   Mesotherapy does not create new follicles — it strengthens the follicles you already have, accelerates the transition of telogen-phase hairs into anagen and slows ongoing loss. It is limited in completely bald areas (Norwood V+); it is effective in the early-to-moderate stages.

2. How many sessions are needed?

   The loading phase is 4-6 sessions at 2-4 week intervals. This is followed by 2-3 maintenance sessions a year (one every 4-6 months).

3. Which is better, mesotherapy or PRP?

   Efficacy is similar (head-to-head literature). Mesotherapy is a standardised formulation with fixed components; PRP is autologous (your own blood). Combined use is synergistic. The physician chooses according to the patient.

4. Is mesotherapy painful?

   After topical anaesthesia (EMLA, 30-40 min), most patients describe a mild stinging sensation. It is generally less painful than PRP (autologous plasma is more viscous, so the feeling of pressure is greater).

5. Can mesotherapy be done during pregnancy?

   No. Pregnancy category data for the components are limited; under the precautionary principle, mesotherapy is contraindicated during pregnancy and breastfeeding. It can be started 6-12 months after delivery (depending on breastfeeding status).

6. If I stop mesotherapy sessions, will my hair fall out?

   If the gains achieved after the loading phase are not maintained, there is a tendency to return gradually (within 6-12 months) to baseline. This is not a harmful effect of mesotherapy — it is the progression of the underlying AGA. Long-term preservation is achieved with topical minoxidil + maintenance sessions.

Dr. Hamza Gemici's Commentary

"In my 30 years of practice, hair mesotherapy has been the backbone of first-line non-surgical treatment, particularly for patients aged 30-50 with early-to-moderate androgenetic alopecia and for postpartum/post-stress telogen effluvium. Managing expectations realistically is critical: it is not 'magic' but bio-activation — a protocol that optimises the follicles you already have, slows the rate of shedding and thickens existing hair. I get the most favourable results with a foundation of topical minoxidil, physician-approved oral therapy (if needed) and a rotating mesotherapy/PRP combination. Patient adherence — not neglecting maintenance sessions — is what determines success."

— Dr. Hamza Gemici

Sources and References

1. Donovan JC, Bergfeld WF, et al. "Mesotherapy in the management of androgenetic alopecia: a systematic review."
   Skin Appendage Disorders, 2019
   URL: https://pubmed.ncbi.nlm.nih.gov/31388494/
2. El-Garem YF, Awad AM. "Mesotherapy in the treatment of telogen effluvium in women."
   J Cosmet Dermatol, 2014
   URL: https://pubmed.ncbi.nlm.nih.gov/25196686/
3. Ferraris C, et al. "Procapil peptide complex in androgenetic alopecia: clinical trial."
   J Eur Acad Dermatol Venereol, 2010
   URL: https://pubmed.ncbi.nlm.nih.gov/20384668/
4. Saceda-Corralo D, et al. "Comparison of PRP and mesotherapy in androgenetic alopecia."
   J Dermatolog Treat, 2018
   URL: https://pubmed.ncbi.nlm.nih.gov/29991295/
5. Coppola RE, et al. "Safety profile of capillary mesotherapy: a multicentre study."
   J Cosmet Dermatol, 2020
   URL: https://pubmed.ncbi.nlm.nih.gov/32384178/
6. International Society of Mesotherapy (SIM) — Clinical Guidelines for Capillary Mesotherapy, 2022
   URL: https://www.societeinternationalemesotherapie.org/

Last updated: 20 May 2026 · Medical editor: Dr. Hamza Gemici